Savvy Updates 9/18/23:  Nemaura sugarBEAT Non-Invasive CGM (NI CGM) Study, Apple NI CGM?, Glucagon Legislation, Carbs or Fats for Men or Women, Bonatra Smart Ring,  What to Order at Starbucks

Savvy Updates 9/18/23: Nemaura sugarBEAT Non-Invasive CGM (NI CGM) Study, Apple NI CGM?, Glucagon Legislation, Carbs or Fats for Men or Women, Bonatra Smart Ring, What to Order at Starbucks

Nemaura completes study of sugarBEAT glucose monitor posted by MedicalDevice-Network.com, 12 September 2023.   Nemaura Medical has completed a 100-patient study of the non-invasive and flexible continuous glucose monitor sugarBEAT.  Carried...
Savvy Updates 9/11/23: Medtronic Sued for InPen Data Share, Tandem/Insulet Stock Drops, Verapamil Preserves IGF-1, Beta Bionics iLet Simulator, AMA Physician Burnout, Panel on Prevention of T1D

Savvy Updates 9/11/23: Medtronic Sued for InPen Data Share, Tandem/Insulet Stock Drops, Verapamil Preserves IGF-1, Beta Bionics iLet Simulator, AMA Physician Burnout, Panel on Prevention of T1D

Medtronic sued for allegedly sharing ‘treasure trove’ of diabetes patient data with Google by Nick Paul Taylor for MedTechDive.com, 5 September 2023. The case centers on the app that accompanies Medtronic’s smart insulin pen. Medtronic created the app to help patients...
Savvy Updates 9/5/23: InsuletGets TRO Against EOFlow, Beta Bionics Raises $100M, Research Grant for Liver Targeted Insulin, History/Future or DIY “Bionic Pancreas”, 1st Ten Drugs for Medicare Price Negoation, WellDoc’s Blue Star Gets FDA Clearance, Men & Women Differ in Cardiac Arrest Symptoms, CGM Companies Go Mainstream

Savvy Updates 9/5/23: InsuletGets TRO Against EOFlow, Beta Bionics Raises $100M, Research Grant for Liver Targeted Insulin, History/Future or DIY “Bionic Pancreas”, 1st Ten Drugs for Medicare Price Negoation, WellDoc’s Blue Star Gets FDA Clearance, Men & Women Differ in Cardiac Arrest Symptoms, CGM Companies Go Mainstream

Insulet gains amid winning TRO in dispute with EOFlow, CEO insider buy by Joshua Fineman for SeekingAlpha.com, 30 August 2023.   Insulet rose 8.1% at least partly after the insulin pump maker was granted a temporary restraining order in a trade secrets case...
Savvy Updates 8/28/23:  Roche Solo MicroPump FDA-Approved, Altucell Islet Cell Encapsulation, Abata Therapeutics TReg Therapies, Dexcom/Abbott Go Direct to Customer, Lots of NEW Advanced Diabetes Tech, Insulet Stock Down, Medtronic Q1 2024 Earnings,

Savvy Updates 8/28/23: Roche Solo MicroPump FDA-Approved, Altucell Islet Cell Encapsulation, Abata Therapeutics TReg Therapies, Dexcom/Abbott Go Direct to Customer, Lots of NEW Advanced Diabetes Tech, Insulet Stock Down, Medtronic Q1 2024 Earnings,

FDA Approves New Tubeless Insulin Pump by Miriam Tucker for MedScape.com, 23 August 2023. The US Food and Drug Administration (FDA) has granted clearance for Roche’s Accu-Chek Solo micropump system, a tubing-free “patch” pump for people with diabetes...
Savvy Updates 8/21/23: Insulet Sues EOFlow for Patent Infringement, Lilly/Sigilon Deal Complete, Amazon Pharmacy Gives Insulin Coupons, DEKA Pump 501K Approval, Oramed’s Human Insulin, Antidepressants & T1D, Cannabis & DKA, Female T1D SD, 2 Videos from TheSugarScience

Savvy Updates 8/21/23: Insulet Sues EOFlow for Patent Infringement, Lilly/Sigilon Deal Complete, Amazon Pharmacy Gives Insulin Coupons, DEKA Pump 501K Approval, Oramed’s Human Insulin, Antidepressants & T1D, Cannabis & DKA, Female T1D SD, 2 Videos from TheSugarScience

Insulet claims EOFlow copied patch-pump design in patent suit by Elise Reuter for MedTechDive.com, 15 August 2023. Insulet claims that EOFlow’s EOPatch insulin pump violates three of the patents for its Omnipod patch pump and that the product designs “are practically...
Skip to content